Abstract C193: Biological evaluation of novel multi-targeted Aurora-B kinase inhibitor TAK-901 in xenograft models
Takashi Satou(Takeda (Japan)), Ron de Jong(Takeda (United States)), Seigo Ishino(Takeda (United States)), Bheema Paraselli(Takeda (United States)), Lilly Zhang(Takeda (United States)), Robyn Fabrey(Takeda (United States)), Bumsup Lee(Takeda (United States)), Mika Teratani(Takeda (United States)), Takashi Hoshino(Takeda (United States)), Toshiyuki Nomura(Mitsubishi Group (Japan)), Yoshikazu Ohta(University of Miyazaki), Pamela Farrell(Takeda (United States)), Sarah Elliott(United States Geological Survey)
Cited by 0
Related Papers
Role for Akt3/Protein Kinase Bγ in Attainment of Normal Brain Size
|Molecular and Cellular Biology|2005|549
Structural Analysis of the Mechanism of Inhibition and Allosteric Activation of the Kinase Domain of HER2 Protein
|Journal of Biological Chemistry|2011|441
Potent and selective inhibitors of Akt kinases slow the progress of tumors <i>in vivo</i>
|Molecular Cancer Therapeutics|2005|244
Design and Synthesis of Novel Human Epidermal Growth Factor Receptor 2 (HER2)/Epidermal Growth Factor Receptor (EGFR) Dual Inhibitors Bearing a Pyrrolo[3,2-<i>d</i>]pyrimidine Scaffold
|Journal of Medicinal Chemistry|2011|223
Structure-Based Approach for the Discovery of Pyrrolo[3,2-<i>d</i>]pyrimidine-Based EGFR T790M/L858R Mutant Inhibitors
|ACS Medicinal Chemistry Letters|2012|171